Bellwether Bio


Bellwether is a UW Genomics start-up developing new tools to enable early detection of cancer and other diseases through "Liquid Biopsy," The company's technology can be used to trace tell-tale DNA fragments circulating within a patient's blood to the tissues/organs of origin.

Click here to access the company's website.

Recent News

UW Spinout Bellwether Bio Raises $2.8M in Seed Financing

February 10, 2017

Bellwether Bio, a liquid biopsy startup that recently spun out of the University of Washington, has raised almost $2.8 million in seed financing. ... [Click for more] ...